Anebulo Pharmaceuticals Inc (ANEB) — Financial Flexibility Index
Anebulo Pharmaceuticals Inc (ANEB) has a Financial Flexibility Index of -0.88x as of December 2025. Free cash flow of $-1.31 Million (operating CF $-1.31 Million minus capex $0.00) represents -1% of total liabilities ($1.49 Million). Check Anebulo Pharmaceuticals Inc (ANEB) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anebulo Pharmaceuticals Inc Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Anebulo Pharmaceuticals Inc across 6 annual periods. For the full cash flow conversion analysis, see Anebulo Pharmaceuticals Inc (ANEB) cash conversion ratio.
Annual Financial Flexibility Index for Anebulo Pharmaceuticals Inc (2020–2025)
Year-by-year free cash flow to debt coverage for Anebulo Pharmaceuticals Inc. Explore Anebulo Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.02x | $-6.35 Million | $-6.35 Million | $487.69K | ▲ +58.1% |
| 2024 | -31.05x | $-8.09 Million | $-8.09 Million | $260.58K | ▼ -242.7% |
| 2023 | -9.06x | $-9.68 Million | $-9.68 Million | $1.07 Million | ▲ +14.6% |
| 2022 | -10.61x | $-5.44 Million | $-5.44 Million | $512.53K | ▲ +47.4% |
| 2021 | -20.16x | $-4.87 Million | $-4.87 Million | $241.63K | ▼ -2893.3% |
| 2020 | -0.67x | $-150.77K | $-150.77K | $223.87K | — |